AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
1min snip
The Science and Supply of GLP-1s with Chronis Manolis
Raising Health
Balancing Cost and Effectiveness of Therapies
Focusing on treating the highest risk individuals, competing with better efficacy and lower prices, and proving the cost benefit of therapies is essential. Pharmaceutical companies need to demonstrate the return on investment and move towards a whole-person approach to patient benefits. While there is a widespread coverage for diabetes treatments, weight loss therapies are not considered cost-effective currently.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode